Richard W. Mott, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 95,000 shares at $21.90 ($2.1M) on 2022-11-30, disclosed to the SEC on 2022-12-02.
Open-market sale of $2.1M TMCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.90 | 75,000 | $1.6M | 77.4% |
| 2 | $24.00 | 20,000 | $480K | 22.6% |
| Total | $22.34 avg | 95,000 | $2.1M | 100% |
| Filing → |
| TMCI | BUY | 2024-05-13 | $1.1M | — | Filing → |
| TMCI | SELL | 2023-04-10 | $105K | — | Filing → |
| TMCI | SELL | 2023-04-05 | $415K | — | Filing → |